No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RMD241220P220000
- 0.25
- -0.15-37.50%
15min DelayClose Dec 19 16:00 ET
0.25High0.25Low
0.25Open0.40Pre Close10 Volume439 Open Interest220.00Strike Price250.00Turnover114.96%IV5.11%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type-0.0775Delta0.0171Gamma771.93Leverage Ratio-1.6178Theta-0.0002Rho-59.81Eff Leverage0.0107Vega
Intraday
- 5D
- Daily
News
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
With 74% Institutional Ownership, ResMed Inc. (NYSE:RMD) Is a Favorite Amongst the Big Guns
We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Stifel Maintains ResMed(RMD.US) With Hold Rating, Maintains Target Price $250
ResMed Analyst Ratings